Deucravacitinib Interactions
There are 472 drugs known to interact with deucravacitinib, along with 4 disease interactions. Of the total drug interactions, 372 are major, 91 are moderate, and 9 are minor.
- View all 472 medications that may interact with deucravacitinib
- View deucravacitinib disease interactions (4)
Most frequently checked interactions
View interaction reports for deucravacitinib and the medicines listed below.
- 5-HTP (5-hydroxytryptophan)
- Actonel (risedronate)
- Advair Diskus (fluticasone / salmeterol)
- Afrin (oxymetazoline nasal)
- Afrin Sinus (oxymetazoline nasal)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Aleve (naproxen)
- Ambien (zolpidem)
- Aspercreme Maximum Strength Lidocaine Patch (lidocaine topical)
- Astepro (azelastine nasal)
- Ativan (lorazepam)
- Atrovent HFA (ipratropium)
- B-12 Dots (cyanocobalamin)
- B-Complex with B-12 (multivitamin)
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bimzelx (bimekizumab)
- Bystolic (nebivolol)
- Calcium 600 D (calcium / vitamin d)
- Calcium, Magnesium and Zinc (multivitamin with minerals)
- CellCept (mycophenolate mofetil)
- Citracal + D (calcium / vitamin d)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flax Seed Oil (flax)
- Nexium (esomeprazole)
- Plaquenil (hydroxychloroquine)
- Rinvoq (upadacitinib)
- Vitamin B12 (cyanocobalamin)
- Zyrtec (cetirizine)
Deucravacitinib disease interactions
There are 4 disease interactions with deucravacitinib which include:
Report options
QR code containing a link to this page
More about deucravacitinib
- deucravacitinib consumer information
- Compare alternatives
- Reviews (13)
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
